Symposium 1: Navigating Oncology Real-World Data Landscape in Asia Pacific Region: Access, Collaboration, and Future Directions for Enhanced Utilization
Tracks
Track 1
| Sunday, October 13, 2024 |
| 10:30 - 12:00 |
| Yasuda Auditorium |
Details
While real-world data (RWD) and real-world evidence (RWE) are widely recognized and utilized in healthcare research, the specific applications and the approaches for access and cross-sector/cross-region collaborations in utilizing oncology RWD in the Asia Pacific region remain limited.
By overviewing the data sources and environment and use cases from Japan, Taiwan, China, South Korea, and Australia, speakers from diverse background will identify the opportunities and possible approaches of cross-sector collaborations for potential needs of using oncology RWD in the region.
The symposium will enhance participants' awareness of the diverse landscape of RWD sources available for oncology studies in the Asia Pacific region. It aims to foster meaningful cross-regional collaborations, transcending geographic boundaries and promoting the effective utilization of oncology RWD to drive impactful research. Researchers, healthcare professionals, policymakers, and industry representatives both in the Asia Pacific region and outside of the region will benefit from attending.
Speaker
Dr. Kiyoshi Kubota
President
NPO Drug Safety Research Unit Japan
Presenter
Biography
Dr. Kiyoshi Kubota is a physician and a pharmacoepidemiologist. From 1991 to 1996 he worked at the Drug Safety Research Unit in England. He was Associate Professor (till 2008) and Professor (after 2008) of Department of Pharmacoepidemiology in Tokyo University from 1996 to 2014. He has been a member of the International Society for Pharmacoepidemiology (ISPE) since 1995. He worked as an Executive Committee Member of ISPE between 2015 August and 2018 August including 1 year between 2016 and 2017 when he was President of ISPE. He has been President of Japanese Society for Pharmacoepidemiology (JSPE) for 11 years from 2008 to 2019. He organized the ISPE’s 2nd Asian meeting in 2007 and the 5th Asian meeting in 2010 in Tokyo as the congress chair. He is currently President of NPO Drug Safety Research Unit Japan where he has been working since 2001.
Mr. Edward Chia-Cheng Lai
Educational Program Director
School Of Pharmacy, Institute Of Clinical Pharmacy And Pharmaceutical Sciences
Presenter
Biography
Associate Professor Edward Chia-Cheng Lai specializes in pharmacoepidemiology, with a focus on research projects using cross-center and cross-national databases. He has received solid training in research methodology. He has published approximately 90 research papers in top-tier journals, including BMJ, Annals of Internal Medicine, and Clinical Pharmacology & Therapeutics. His articles have been cited over 1,000 times. Recognized for his outstanding performance in research methodology, he was invited to become the Associate Editor of the official journal of the International Society for Pharmacoepidemiology (ISPE), Pharmacoepidemiology and Drug Safety, in 2013. He reviews over 30 research papers annually and invites more than 100 domestic and international reviewers to assist in the peer-review process, demonstrating significant academic influence.
Yvonne Lee
Head of Real-World Evidence Asia Pacific
IQVIA Solutions Asia
Presenter
Biography
Yvonne Lee holds a PhD in Medicine from University of New South Wales and Master of Public Health from Mount Sinai School of Medicine, New York. She has more than 19 years of global working experience across different organizations including academia, government, pharmaceutical and medtech industry. Yvonne specialized in real- world clinical evidence generation, health economics, health technology assessments and market access. She has established track record publications and worked in the following therapeutic areas: oncology, infectious disease, diabetes, cardiovascular and stroke. She received further training in cancer epidemiology at International Agency for Research on Cancer (IARC), patient centered care at US Patient-Centered Outcome Research Institute (PCORI) and alumni of Eureka 3rd International Certificate Program in Translational Medicine (2010). Yvonne drives multi-stakeholder collaborations to improve patient access to innovative medical technologies across Asia Pacific and she advocates for patient-centered care
Moderator
Lei Chen
Senior Principal Scientist
Merck Sharp & Dohme
Benjamin Daniels
UNSW Sydney
